HC Wainwright Downgrades Angion Biomedica
Last month, Angion Biomedica Corp (NASDAQ:ANGN) discontinued the JUNIPER Phase 2 dose-finding trial of ANG-3070 in primary proteinuric kidney diseases, specifically focal…
SVB Leerink Picks This Well-Positioned NK Cell-Focused Stock, Sees 117% Upside
SVB Leerink initiated coverage on Nkarta Inc (NASDAQ:NKTX) with an Outperform rating and a price target of $30 (117% implied upside). The…
WHO, UNICEF Sound Alarm As Pandemic Leads Largest Fall In Kids Vaccinations In 30 Years
According to the United Nations Children’s Fund (UNICEF) and the World Health Organization (WHO), approximately 25 million children worldwide missed routine…
AbbVie To Submit European Application For Epcoritamab In Lymphoma Setting Later In 2022
Genmab A/S (NASDAQ:GMAB) has announced that AbbVie Inc (NASDAQ:ABBV) will submit a conditional marketing authorization application with the European Medicines Agency…
Algernon Posts Mixed Bag Results From Mid Stage Chronic Cough Study
Algernon Pharmaceuticals Inc (OTC:AGNPF) has announced topline data showing that it has met the co-primary endpoint in its Phase 2 proof…
PMV Pharma, Merck Ink Clinical Trial Collaboration For Combination Study In Solid Tumors
PMV Pharmaceuticals Inc (NASDAQ:PMVP) has entered into a clinical trial collaboration and supply agreement with Merck & Co Inc (NYSE:MRK) to evaluate PC14586…
Apyx Medical’s Renuvion Scores FDA Approval To Eliminate Sagging Neck
The FDA has granted 510(k) clearance for Apyx Medical Corporation’s (NASDAQ:APYX) Renuvion for subcutaneous dermatological and aesthetic procedures to improve the appearance…
Entera Bio Outlines Pivotal Osteoporosis Trial, Names New CEO
Following its End of Phase 2 Meeting with the FDA, Entera Bio Ltd (NASDAQ:ENTX) has designed the pivotal study for EB613 as…
Medigus’ Polyrizon Inks Agreement To Develop Therapies For Traumatic Spinal Cord Injuries
Polyrizon Ltd, in which Medigus Ltd (NASDAQ:MDGS) owns a 37.03% stake, signed a binding Collaboration Agreement with NurExone Biologic Inc for therapies for traumatic spinal…
GSK Completes Spin Off Of Its Consumer Healthcare Business
GSK plc (NYSE:GSK) has completed the demerger of the Consumer Healthcare business to form the Haleon Group. Reuters reported that shares in…